Cardiex Ltd
ASX:CDX
Cardiex Ltd
ASX:CDX
Price:
0.054 AUD
1.89%
Market Closed
Updated:
May 5, 2024
P/S
Price to Sales
Price to Sales
0.8
Current
13
Median
2.4
Industry
Lower
than median
Lower
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=0.8
Market Cap
/
10.5m
Revenue
12.9m
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| AU |
|
Cardiex Ltd
ASX:CDX
|
10.5m AUD | 0.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 4.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 7.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.4 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 13.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
N/A
2-Years Forward
P/S
0.6
3-Years Forward
P/S
0.2
You don't have any saved screeners yet
